Page 674 - Williams Hematology ( PDFDrive )
P. 674
648 Part VI: The Erythrocyte Chapter 43: Iron Deficiency and Overload 649
261. Ganz T, Goff J, Klasing K, et al: IOD in rhinos—immunity group report: Report from 273. Vaiopoulos G, Papanikolaou G, Politou M, et al: Arthropathy in juvenile hemochroma-
the Immunity, Genetics and Toxicology Working Group of the International Workshop tosis. Arthritis Rheum 48(1):227–230, 2003.
on Iron Overload Disorder in Browsing Rhinoceros (February 2011). J Zoo Wildl Med 274. Ko C, Siddaiah N, Berger J, et al: Prevalence of hepatic iron overload and association
43(3 Suppl):S117–S119, 2012. with hepatocellular cancer in end-stage liver disease: Results from the National Hemo-
262. Yang T, Brittenham GM, Dong WQ, et al: Deferoxamine prevents cardiac hypertro- chromatosis Transplant Registry. Liver Int 27(10):1394–1401, 2007.
phy and failure in the gerbil model of iron-induced cardiomyopathy. J Lab Clin Med 275. Ryan CF, Sendi H, Bonkovsky HL: Hepatitis C, porphyria cutanea tarda and liver iron:
142(5):332–340, 2003. An update. Liver Int 32(6):880–893, 2012.
263. Brittenham GM, Kuryshev YA, Obejero-Paz CA, et al: Yang et al response. J Lab Clin 276. Camaschella C, Roetto A, De GM: Juvenile hemochromatosis. Semin Hematol
Med 141(6):420–422, 2003. 39(4):242–248, 2002.
264. Wood JC, Otto-Duessel M, Gonzalez I, et al: Deferasirox and deferiprone remove car- 277. Bottomley SS: Secondary iron overload disorders. Semin Hematol 35(1):77–86, 1998.
diac iron in the iron-overloaded gerbil. Transl Res 148(5):272–280, 2006. 278. Jensen PD: Evaluation of iron overload. Br J Haematol 124(6):697–711, 2004.
265. Hershko C, Link G, Konijn AM, et al: The iron-loaded gerbil model revisited: Effects of 279. Poullis A, Moodie SJ, Ang L, et al: Routine transferrin saturation measurement in liver
deferoxamine and deferiprone treatment. J Lab Clin Med 139(1):50–58, 2002. clinic patients increases detection of hereditary haemochromatosis. Ann Clin Biochem
266. Zhou XY, Tomatsu S, Fleming RE, et al: HFE gene knockout produces mouse model of 40(Pt 5):521–527, 2003.
hereditary hemochromatosis. Proc Natl Acad Sci U S A 95(5):2492–2497, 1998. 280. Yin D, Kulhalli V, Walker AP: Raised serum ferritin concentration in hereditary
267. Donovan A, Lima CA, Pinkus JL, et al: The iron exporter ferroportin/Slc40a1 is essen- hyperferritinemia cataract syndrome is not a marker for iron overload. Hepatology
tial for iron homeostasis. Cell Metab 1(3):191–200, 2005. 59(3):1204–1206, 2014.
268. Lesbordes-Brion JC, Viatte L, Bennoun M, et al: Targeted disruption of the hepcidin 1 281. Brissot P, Bardou-Jacquet E, Jouanolle AM, et al: Iron disorders of genetic origin: A
gene results in severe hemochromatosis. Blood 108(4):1402–1405, 2006. changing world. Trends Mol Med 17(12):707–713, 2011.
269. Meynard D, Kautz L, Darnaud V, et al: Lack of the bone morphogenetic protein BMP6 282. Porter JB: Practical management of iron overload. Br J Haematol 115(2):239–252, 2001.
induces massive iron overload. Nat Genet 41(4):478–481, 2009. 283. Hoffbrand AV, Taher A, Cappellini MD: How I treat transfusional iron overload. Blood
270. Andriopoulos B, Jr, Corradini E, Xia Y, et al: BMP6 is a key endogenous regulator of 120(18):3657–3669, 2012.
hepcidin expression and iron metabolism. Nat Genet 41(4):482–487, 2009. 284. Ogimoto M, Anzai K, Takenoshita H, et al: Criteria for early identification of aceru-
271. Carroll GJ, Breidahl WH, Bulsara MK, et al: Hereditary hemochromatosis is character- loplasminemia. Intern Med 50(13):1415–1418, 2011.
ized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 285. Grandchamp B, Hetet G, Kannengiesser C, et al: A novel type of congenital hypochro-
63(1):286–294, 2011. mic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Blood
272. Elmberg M, Hultcrantz R, Simard JF, et al: Increased risk of arthropathies and joint 118(25):6660–6666, 2011.
replacement surgery in patients with genetic hemochromatosis: A study of 3,531
patients and their 11,794 first-degree relatives. Arthritis Care Res (Hoboken) 65(5):
678–685, 2013.
Kaushansky_chapter 43_p0627-0650.indd 649 9/17/15 6:27 PM

